Home
Home
Quick search
Order ImmunoCAP® Products Online About us Products ImmunoCAP Design Methodology Product Performance Binding Capacity Comparison RAST versus ImmunoCAP Methods of Assay Calibration Quantitation Requires Parallelism Dilution Recovery Linearity Testing Comparison Quantitation Requires Precision Correlation Coefficient Quality Assessment Performance Phadia Electronic Directions For Use Phadia Automation Phadia Software U.S. Product Catalog Material Safety Data Sheets Customer Care Phadia US Careers News Journal & Web Publications Trade shows Links Site Map
Correlation Coefficient

Close To An Ideal Lab Determination

In clinical tests, ImmunoCAP technology has been demonstrated to be close to an ideal lab determination where the correlation coefficient is 100% or 1.0.
 
 
In a recent study illustrated above, laboratories evaluated more than 12,000 blinded serum samples containing various levels of specific IgE, using a number of lab tests in order to compare accuracy and precision.
 
ImmunoCAP technology produced the best assessments (0.96-0.98), performing almost as well as the ideal standard. RAST' tests ranged from 0.65 to 0.82. As the researchers concluded, "The ImmunoCAP assay [Pharmacia CAP system] performed well when compared with the standard of an ideal assay, although other assays often did not perform up to this standard." (1)
 
Impact of Poor Performance For Tests With R2 Below 0.80
"Given the dilution range used in this study, values of R-Square below approximately 0.80 generally reflect poor performance in the ability to correctly detect levels of specific IgE antibodies. Only ImmunoCAP had consistently acceptable R-Square values, suggesting good performance in their ability to correctly detect the concentrations of specific IgE antibodies across the different samples and allergens." (1)

Reference

1. Williams PB, Barnes JH, Szeinbach SL, Sullivan T. Analytical precision and accuracy of commercial immunoassays for specific IgE: establishing a standard. J Allergy Clin Immunol. 2000;105(6):1221-1230.